Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease
Related Posts
Sharp ASP, Dohad SY, Weinberg I, Kurzyna M, Davis HC, Stepniewski J, Perkowski PE, Holden A, West FM, Keeling WB, Parikh SA, Moriarty JM. Outcome[...]
Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]
Khan S, Abbas F, Hassan M, Hussain M, Ahmed M, Ahsan A, Qureshi S, Khalid N, Sajjad A, Baig M, Waqas SA, Fonarow GC, Greene[...]